These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11949846)

  • 21. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
    Fukumoto S; Shirato H; Shimzu S; Ogura S; Onimaru R; Kitamura K; Yamazaki K; Miyasaka K; Nishimura M; Dosaka-Akita H
    Cancer; 2002 Oct; 95(7):1546-53. PubMed ID: 12237924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer.
    Mac Manus MP; Matthews JP; Wada M; Wirth A; Worotniuk V; Ball DL
    Cancer; 2006 Mar; 106(5):1110-6. PubMed ID: 16432830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome following radiotherapy for loco-regionally recurrent non-small cell lung cancer.
    Foo K; Gebski V; Yeghiaian-Alvandi R; Foroudi F; Cakir B
    Australas Radiol; 2005 Apr; 49(2):108-12. PubMed ID: 15845045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
    Werner-Wasik M; Swann RS; Bradley J; Graham M; Emami B; Purdy J; Sause W
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):385-90. PubMed ID: 17869017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
    Fang LC; Komaki R; Allen P; Guerrero T; Mohan R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):108-16. PubMed ID: 16904517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment?
    Kramer GW; Gans S; Ullmann E; van Meerbeeck JP; Legrand CC; Leer JW
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1388-93. PubMed ID: 15050314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome.
    Pemberton LS; Din OS; Fisher PM; Hatton MQ
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):161-7. PubMed ID: 19111452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palliative treatment of advanced non small cell lung cancer with weekly fraction radiotherapy.
    Bhatt ML; Mohani BK; Kumar L; Chawla S; Sharma DN; Rath GK
    Indian J Cancer; 2000 Dec; 37(4):148-52. PubMed ID: 12018566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative percutaneous radiotherapy in non-small-cell lung cancer.
    Budach W; Belka C
    Lung Cancer; 2004 Aug; 45 Suppl 2():S239-45. PubMed ID: 15552805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
    Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
    Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer.
    Kim DW; Shyr Y; Shaktour B; Akerley W; Johnson DH; Choy H
    Lung Cancer; 2005 Nov; 50(2):235-45. PubMed ID: 16043262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis.
    Lee HW; Choi JH; Lim HY; Park JS; Kim HC; Kang S; Oh YT; Chun M; Sheen SS; Oh YJ; Park KJ; Hwang SC
    Neoplasma; 2006; 53(1):30-6. PubMed ID: 16416010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
    Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy alone in elderly patients with medically inoperable stage IIIA and IIIB non-small cell lung cancer.
    Tombolini V; Bonanni A; Donato V; Raffetto N; Santarelli M; Valeriani M; Enrici RM
    Anticancer Res; 2000; 20(6C):4829-33. PubMed ID: 11205228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer].
    Wang YM; Guo LJ; Li LS; Li P; Zheng J; Li L
    Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Palliative radiotherapy in non-small cell bronchial carcinoma].
    Slotman BJ; Njo KH; Karim AB
    Ned Tijdschr Geneeskd; 1993 Oct; 137(42):2144-8. PubMed ID: 7694162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.